Dipak Consortium[Corporate Author] - Search Results

Year	Number of Results
2013	2
2014	2
2015	1
2016	1
2017	4
2018	5
2019	1
2020	2
2021	4
2022	2
2023	5
2024	5

1

Matrix Metalloproteinase-7 in Urinary Extracellular Vesicles Identifies Rapid Disease Progression in Autosomal Dominant Polycystic Kidney Disease.

van Heugten MH, Blijdorp CJ, Arjune S, van Willigenburg H, Bezstarosti K, Demmers JAA, Musterd-Bhaggoe U, Meijer E, Gansevoort RT, Zietse R, Hayat S, Kramann R, Müller RU, Salih M, Hoorn EJ; DIPAK Consortium. van Heugten MH, et al. J Am Soc Nephrol. 2024 Mar 1;35(3):321-334. doi: 10.1681/ASN.0000000000000277. Epub 2023 Dec 11. J Am Soc Nephrol. 2024. PMID: 38073039

2

Higher beta-hydroxybutyrate ketone levels associated with a slower kidney function decline in ADPKD.

Knol MGE, Bais T, Geertsema P, Connelly MA, Bakker SJL, Gansevoort RT, van Gastel MDA; DIPAK Consortium. Knol MGE, et al. Nephrol Dial Transplant. 2024 Apr 26;39(5):838-847. doi: 10.1093/ndt/gfad239. Nephrol Dial Transplant. 2024. PMID: 37974030 Free PMC article.

3

Kidney phosphate wasting predicts poor outcome in polycystic kidney disease.

Xue L, Geurts F, Meijer E, de Borst MH, Gansevoort RT, Zietse R, Hoorn EJ, Salih M; DIPAK Consortium. Xue L, et al. Nephrol Dial Transplant. 2024 Jun 28;39(7):1105-1114. doi: 10.1093/ndt/gfad247. Nephrol Dial Transplant. 2024. PMID: 37985930 Free PMC article.

4

Validation of the Mayo Imaging Classification System for Predicting Kidney Outcomes in ADPKD.

Bais T, Geertsema P, Knol MGE, van Gastel MDA, de Haas RJ, Meijer E, Gansevoort RT; DIPAK Consortium. Bais T, et al. Clin J Am Soc Nephrol. 2024 May 1;19(5):591-601. doi: 10.2215/CJN.0000000000000427. Epub 2024 Feb 26. Clin J Am Soc Nephrol. 2024. PMID: 38407866

5

Prostaglandin E2, Osmoregulation, and Disease Progression in Autosomal Dominant Polycystic Kidney Disease.

Geurts F, Xue L, Kramers BJ, Zietse R, Gansevoort RT, Fenton RA, Meijer E, Salih M, Hoorn EJ; DIPAK Consortium. Geurts F, et al. Clin J Am Soc Nephrol. 2023 Nov 1;18(11):1426-1434. doi: 10.2215/CJN.0000000000000269. Epub 2023 Aug 14. Clin J Am Soc Nephrol. 2023. PMID: 37574650 Free PMC article.

6

A stepwise approach for effective management of chronic pain in autosomal-dominant polycystic kidney disease.

Casteleijn NF, Visser FW, Drenth JP, Gevers TJ, Groen GJ, Hogan MC, Gansevoort RT; DIPAK Consortium. Casteleijn NF, et al. Nephrol Dial Transplant. 2014 Sep;29 Suppl 4(Suppl 4):iv142-53. doi: 10.1093/ndt/gfu073. Nephrol Dial Transplant. 2014. PMID: 25165181 Free PMC article. Review.

7

Serum bile acids associate with liver volume in polycystic liver disease and decrease upon treatment with lanreotide.

Dekker SEI, Bierau J, Giera M, Blomberg N, Drenth JPH, Mayboroda OA, de Fijter JW, Soonawala D; DIPAK Consortium. Dekker SEI, et al. Eur J Clin Invest. 2024 Apr;54(4):e14147. doi: 10.1111/eci.14147. Epub 2023 Dec 9. Eur J Clin Invest. 2024. PMID: 38071418

8

Serum bicarbonate is associated with kidney outcomes in autosomal dominant polycystic kidney disease.

Blijdorp CJ, Severs D, Musterd-Bhaggoe UM, Gansevoort RT, Zietse R, Hoorn EJ; DIPAK Consortium. Blijdorp CJ, et al. Nephrol Dial Transplant. 2021 Dec 2;36(12):2248-2255. doi: 10.1093/ndt/gfaa283. Nephrol Dial Transplant. 2021. PMID: 33377160 Free PMC article.

9

Incident Gallstones During Somatostatin Analog Treatment are Associated with Acute Biliary Complications Especially After Discontinuation.

Aapkes SE, de Haas RJ, Bernts LHP, Blijdorp CJ, Dekker SEI, van Gastel MDA, Meijer E, Veldman A, Drenth JPH, Gansevoort RT; DIPAK consortium. Aapkes SE, et al. Drugs R D. 2021 Jun;21(2):179-188. doi: 10.1007/s40268-021-00342-7. Epub 2021 Mar 29. Drugs R D. 2021. PMID: 33779943 Free PMC article. Clinical Trial.

10

Hepatic Cyst Infection During Use of the Somatostatin Analog Lanreotide in Autosomal Dominant Polycystic Kidney Disease: An Interim Analysis of the Randomized Open-Label Multicenter DIPAK-1 Study.

Lantinga MA, D'Agnolo HM, Casteleijn NF, de Fijter JW, Meijer E, Messchendorp AL, Peters DJ, Salih M, Spithoven EM, Soonawala D, Visser FW, Wetzels JF, Zietse R, Drenth JP, Gansevoort RT; DIPAK Consortium. Lantinga MA, et al. Drug Saf. 2017 Feb;40(2):153-167. doi: 10.1007/s40264-016-0486-x. Drug Saf. 2017. PMID: 27995519 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Results by year